header


08.30 - 08.40

Welcome

P. Jaïs, Bordeaux, F. Sacher, Bordeaux - FRA


08.40 - 10.00

SESSION 1: MAPPING: HOW MUCH IS NEEDED?

Chairs: A. Frontera, Milano - ITA - S. Mahapatra, Mineapolis - USA


08.40 - 09.00

Debate: My ablation catheter is all I need

Pro

C. De Chillou, Nancy - FRA

Con

P. Della Bella, Milano - ITA


09.00 - 09.10

Next generation of multidirectional signals

F. Sacher, Bordeaux - FRA


09.10 - 09.20

Advanced computer processing for VT maps

S. Pagani, Milano - ITA


09.20 - 09.30

Fusing imaging and Body Surface Mapping?

H. Cochet, Bordeaux - FRA


09.30 - 09.40

How to democratize VT ablation?

S. Mahapatra, Mineapolis - USA

Discussion 20’


10.30 - 12.00

SESSION 2: THE RIGHT VENTRICLE WORLD

Chairs: F. Sacher, Bordeaux - FRA - Katja Zeppenfeld, Leiden - NLD


10.30 - 10.40

RV electrophysiology and the genesis of arrhythmias

R. Coronel, Amsterdam - NLD


10.40 - 10.50

The RV in ultra-endurance athletes, arrhythmias, function, MRI aspect

F. Schnell, Rennes - FRA


10.50 - 11.00

Importance of electrode size/distance for mapping

E. Anter, Cleveland - USA


11.00 - 11.10

Mapping and Ablation for ARVC, role of epicardial approach

T. Deneke, Bad Neustadt - GER


11.10 - 11.20

Preventive VT Ablation in Fallot: a must?

Katja Zeppenfeld, Leiden - NLD


11.20 - 11.30

VF ablation in Brugada syndrome patients

F. Sacher, Bordeaux - FRA

Discussion 30’


13.00 - 14.50

SESSION 3: ICDS/PACING, ABLATION, MORTALITY

Chairs: P. Jaïs, Bordeaux - FRA - V. Reddy, New York - USA


13.00 - 13.20

Debate: Shocks are deleterious and Ablation should come even before the first shock

Pro

B. Berte, Luzerne - SWI

Con

A. Maass, Groningen - NLD


13.20 - 13.30

Will His pacing become routine? Also in CRT patients?

P. Vijayaraman, Wilkes Barre - USA


13.30 - 13.45

How to avoid complications in VT ablation,

S. Mahida, Liverpool - UK


13.45 - 14.00

Why did we fail to demonstrate mortality benefits with VT Ablation, and are we going to be successful one day?

V. Reddy, New York - USA


14.00 - 14.10

Toward an improved risk stratification, ProFid

G. Hindricks, Leipzig - GER


14.10 - 14.20

Lessons from IVTCC 2.0

F. Marchlinski, Philadelphia - USA


14.20 - 14.30

PARTITA

P. Della Bella, Milano - ITA

Discussion 20’


14.50 - 16.40

SESSION 4: SUBSTRATE BASED ABLATION

Chairs: T. Deneke, Bad Neustadt - GER - J. Kautzner, Prague - CZE


14.50 - 15.20

What makes an isthmus functional? From gap junctions to 3D characteristics

A mathematical approach

E. Ciaccio, New York - USA

A basic science approach

A. Kleber, Boston - USA

A clinical approach

R. Tung, Chicago - USA


15.20 - 16.20

Substrate mapping validated by histology, role of calcifications

Katja Zeppenfeld, Leiden - NLD

VT circuit in Ischemic vs non-Ischemic substrate

P. Santangeli, Philadelphia - USA

CT based approach

T. Deneke, Bad Neustadt - GER

How to combine ultra-HD EGMs, force and local impedance

R. Wakili, Essen - GER

Mapping 2 circuits at the same time?

P. Maury, Toulouse - FRA

What is ventricular remodeling? Is it limited to the scar?

J. Whitaker, Boston - USA

Discussion 20’


17.00 - 18.10

SESSION 5: FOCUS ON MYOCARDITIS / INFLAMMATION

Chairs: P. Della Bella, Milano - ITA - Katja Zeppenfeld, Leiden - NLD


17.00 - 17.10

Insights from histology

Cristina Basso, Padua - ITA


17.10 - 17.20

Challenges in diagnosis and treatment of arrhythmic myocarditis

G. Peretto, Milano - ITA


17.20 - 17.30

Ablation of post myocarditis VT, technique and results

P. Santangeli, Philadelphia - USA


17.30 - 17.40

VT ablation in cardiac sarcoidosis is it beneficial during inflammation?

F. Bogun, Ann Arbor - USA


17.40 - 17.50

How to interpret images across modalities?

H. Cochet, Bordeaux - FRA

Discussion 20’



08.30 - 08.40

Introduction


08.40 - 10.00

SESSION 6: THE YOUNG EP ARENA

Chairs: A. Frontera, Milan - ITA - J. Kautzner, Prague - CZE - Katja Zeppenfeld, Leiden - NLD


08.40 - 08.50

Exploring the relations between Scar-related Ventricular Tachycardia and the Purkinje System

M. Laredo, Paris- FRA

Discussion 5’


08.55 - 09.05

Bundle branch re-entry Tachycardia and scar related VT in a patient with a corrected

Atrioventricular Septal Defect.

R. Evertz, Nijmegen - NLD

Discussion 5’


09.10 - 09.20

Re-do stereotactic radiosurgery for recurrent ventricular tachycardias in a patient

with cardiac fi broma

J. Haskova, Prague - CZE

Discussion 5’


09.25 - 09.35

A septal VT with ubiquitous abnormal EGMs in IDCM.

Discussion 5’

C. Bisceglia, Milan - ITA


10.00 - 10.45

SESSION 7: INTRIGUING PVCS

Chairs: P. Della Bella, Milano - ITA - T. Deneke, Bad Neustadt - GER


10.00 - 10.10

How to land on the spot

A. Frontera, Milano - ITA


10.10 - 10.20

MRI findings in PVC induced CMP

H. Cochet, Bordeaux - FRA


10.20 - 10.30

PVCs in Mitral Valve Prolapse, Risk for SCD, when to Ablate

P. Santangeli, Philadelphia - USA

Discussion 15’


11.00 - 12.00

SESSION 8: PRE-RECORDED VIDEOS

Chairs: E. Anter, Cleveland - USA - F. Bogun, Ann Arbor - USA


11.00 - 11.10

Image-guided simplified VT ablation in post MI patients

P. Jaïs, Bordeaux - FRA


11.10 - 11.20

Dilated CMP

C. Meyer, Duesseldorf - GER


11.20 - 11.30

Papillary Muscle and LV summit

J. Kautzner, Prague - CZE


11.30 - 11.40

How to use small arteries/veins for in depth substrate?

M. Valderrábano, Houston - USA

Discussion 20’


13.00 - 13.45

SESSION 9: SIMULATION OUTPERFORMS EP

Chairs: A. Frontera, Milano - ITA - M. Sermesant, Nice - FRA

Natalia Trayanova, Baltimore - USA

Pro

W.-G. Stevenson, Nashville - USA

Con

Discussion 10’


13.30 - 13.45

I need no computer, just a 12 lead ECG!

F. Marchlinski, Philadelphia - USA


13.45 - 14.55

SESSION 10: HOT TOPICS

Chairs: F. Bogun, Ann Arbor - USA - S. Mahida, Liverpool - UK


13.45 - 13.55

Leadless CRT

M. Strik, Bordeaux - FRA


13.55 - 14.05

Pulsed Field Energy for VT ablation?

V. Reddy, New York - USA


14.05 - 14.15

Use of temperature-controlled irrigated RF ablation in VT

T. Dhanjal, Coventry - UK


14.15 - 14.25

Cryo-energy for VT ablation

T. DePotter, Aalst - BEL


14.25 - 14.35

Sustainability in EP

Julie Boussuge-Roze, Bordeaux - FRA

Discussion 20’